We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.03B
AUM Growth
–
Cap. Flow
+$8.05B
Cap. Flow
% of AUM
100.3%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
2,281
New
2,279
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$264M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
Chevron
CVX
|
+$157M |
| 4 |
Procter & Gamble
PG
|
+$143M |
| 5 |
IBM
IBM
|
+$130M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.36% |
| 2 | Healthcare | 12.61% |
| 3 | Industrials | 12.03% |
| 4 | Financials | 10.68% |
| 5 | Energy | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AstraZeneca
AZN
$263B
| $21.6M | 0.27% |
+457,182
| New | +$23.3M |
|
77
Kroger
KR
$34.8B
| $21.3M | 0.27% |
+1,232,270
| New | +$21M |
|
|
MON
78
DELISTED
Monsanto Co
MON
| $21M | 0.26% |
+212,374
| New | +$22.2M |
|
79
iShares Russell 2000 ETF
IWM
$80.9B
| $20.8M | 0.26% |
+214,815
| New | +$20.5M |
|
|
BCR
80
DELISTED
CR Bard Inc.
BCR
| $20.5M | 0.26% |
+189,068
| New | +$19.7M |
|
81
Corning
GLW
$126B
| $20.5M | 0.26% |
+1,438,705
| New | +$20.9M |
|
|
TUP
82
DELISTED
Tupperware Brands Corporation
TUP
| $19.6M | 0.24% |
+252,688
| New | +$20.4M |
|
83
Kimberly-Clark
KMB
$36.4B
| $18.9M | 0.24% |
+203,159
| New | +$19.6M |
|
84
Amphenol
APH
$188B
| $18.8M | 0.23% |
+1,933,312
| New | +$18.5M |
|
85
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $18.5M | 0.23% |
+455,113
| New | +$19.7M |
|
|
GAP
86
The Gap Inc
GAP
$6.84B
| $18.2M | 0.23% |
+436,382
| New | +$17.2M |
|
|
RTN
87
DELISTED
Raytheon Company
RTN
| $18.2M | 0.23% |
+275,045
| New | +$17.4M |
|
88
Lockheed Martin
LMT
$134B
| $17.9M | 0.22% |
+164,892
| New | +$16.8M |
|
89
Comcast
CMCSA
$79.1B
| $17.8M | 0.22% |
+850,700
| New | +$17.6M |
|
90
Novartis
NVS
$295B
| $17.6M | 0.22% |
+278,079
| New | +$18.1M |
|
91
FedEx
FDX
$74.5B
| $17.4M | 0.22% |
+176,437
| New | +$17.1M |
|
92
Visa
V
$677B
| $17.3M | 0.22% |
+379,316
| New | +$16.6M |
|
93
Bristol-Myers Squibb
BMY
$127B
| $17.3M | 0.22% |
+387,513
| New | +$16.8M |
|
94
Advance Auto Parts
AAP
$3.37B
| $17.1M | 0.21% |
+210,111
| New | +$17.4M |
|
95
Air Products & Chemicals
APD
$66.3B
| $16.9M | 0.21% |
+199,262
| New | +$16.7M |
|
96
iShares MSCI Emerging Markets ETF
EEM
$28B
| $16.8M | 0.21% |
+435,875
| New | +$18.1M |
|
97
Travelers Companies
TRV
$80.8B
| $16.6M | 0.21% |
+208,204
| New | +$17.5M |
|
98
Halliburton
HAL
$27.9B
| $16.6M | 0.21% |
+397,794
| New | +$16.6M |
|
99
iShares Core S&P 500 ETF
IVV
$876B
| $16.3M | 0.2% |
+101,370
| New | +$16.4M |
|
|
WBA
100
DELISTED
Walgreens Boots Alliance
WBA
| $15.9M | 0.2% |
+360,094
| New | +$17.5M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 2,281 positions worth $8.03B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is ExxonMobil: 2,929,510 shares worth $265M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Industrials.
- Glenmede Trust's largest Q2 2013 buy was ExxonMobil: 2,929,510 shares worth $265M.
- Glenmede Trust's ten largest holdings make up 18% of its $8.03B portfolio in Q2 2013.
- Glenmede Trust disclosed 2,281 positions in Q2 2013, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q2 2013, filed 15 Aug 2013.